Journal profile · Multiple
Biotechnology and Genetic Engineering Reviews
ISSN 0264-8725 · eISSN 2046-5556 · Taylor & Francis
Biotechnology and Genetic Engineering Reviews: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.32; subscription journal; community-reported acceptance: easy; indexed in SCIE and Scopus.
The latest issue on the journal's website is from 2024 (Volume 40, Issue 4): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.
Scope
Aims, scope and focus
Biotechnology and Genetic Engineering Reviews is published by Taylor & Francis and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Microbial Metabolic Engineering and Bioproduction, Enzyme Catalysis and Immobilization and CRISPR and Genetic Engineering, together about 21.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Biotechnology and Genetic Engineering Reviews (BGER) is recruiting a new Editor. Any articles submitted prior to the appointment of the new Editor will be placed on hold and authors contacted as necessary. Authors with any questions about current submissions should contact TBGR-peerreview@journals.tandf.co.uk. Biotechnology and Genetic Engineering Reviews is a peer-reviewed journal covering important developments in industrial, agricultural, environmental, and medical applications of biotechnology and therapeutics. The journal has a strong focus on the use of biotechnology to address global challenges through biomedical treatments for diseases, improving agricultural production through plant biotechnology, assisted breeding and genetic engineering, and creating sustainable and cleaner energy sources. The journal will also consider research on marine biotechnology, particularly where it is related to sustainable aquaculture production and bio-energy. Given the 2015 UN Sustainable Development Goals, the journal has a specific interest in articles that focus on applying biotechnology to achieve these targets. The journal welcomes for consideration the following article types: Research Article, Review Article, Data Note, Method, Article Commentary. All articles will be subject to single anonymous peer review. Read the Instructions for Authors for information on how to submit your article.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology8.4%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology6.9%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology6.7%
- Plant tissue culture and regenerationBiochemistry, Genetics and Molecular Biology6.5%
- Transgenic Plants and ApplicationsBiochemistry, Genetics and Molecular Biology6%
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology5.9%
- Biofuel production and bioconversionEngineering5.5%
- Enzyme Production and CharacterizationBiochemistry, Genetics and Molecular Biology5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Engineering Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Engineering | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsPublisher website
Other: ProQuest, AGRICOLA, OCLC
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.32LetPub ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.1Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher) 2025
- 6.3Publisher website ·
- SJR 2026-06
- 0.58LetPub ·
- SJR (publisher) 2025
- 0.58Publisher website ·
- SNIP 2026-06
- 0.7LetPub ·
- SNIP (publisher) 2025
- 0.7Publisher website ·
- h-index
- 36LetPub ·
- h-index
- 68OpenAlex ·
- i10-index
- 408OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 1.06%LetPub ·
Volume
- Downloads per year (publisher)
- 136,000Publisher website ·
Articles by year OpenAlex count · 814 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2023 | 284 | 6 | 1,795 |
| 2022 | 52 | 2 | 1,420 |
| 2021 | 9 | 2 | 340 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 0264-8725
- Electronic ISSN
- 2046-5556
- Latest issue on the website
- Volume 40, Issue 4 (2024)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Biotechnology and Genetic Engineering Reviews
What CAS zone is Biotechnology and Genetic Engineering Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biotechnology and Genetic Engineering Reviews is in Zone 3 of Medicine, and in Zone 2 of the minor category Biotechnology & Applied Microbiology / Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biotechnology and Genetic Engineering Reviews?
The latest impact factor listed by LetPub is 2.32; CiteScore 6.3, h-index 68.
Which databases index Biotechnology and Genetic Engineering Reviews?
According to LetPub and DOAJ records, Biotechnology and Genetic Engineering Reviews is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and CAB Abstracts; that list has not been checked against each database.
Is Biotechnology and Genetic Engineering Reviews open access, and what is the APC?
Biotechnology and Genetic Engineering Reviews is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .